Matritech other research news

The Cambridge, Mass., company received a $100,000 Phase I SBIR from the National Cancer Institute to determine the clinical potential of NMPs as markers for colon cancer.

NMPs play a fundamental role in gene expression, and detecting differences in the types and amounts of NMPs may provide diagnostic information about cellular abnormalities, NMPS said. ...